TP53 network (WP1742)
Homo sapiens
P53 is not a lonely genome guardian, it operates with the assistance of p73 and p63 within a complex network including distinct but complementary pathways. This protein family presents a high level of sequence homology in its DNA binding domain. The complexity of the family has been enriched by the alternatively spliced forms of the genes. At present pathway, the alternatively spliced forms of p63 and p73 and how they interact with p53 are shown . However, little is known about the transcriptional regulation of p53 family members. Further studies will tell us whether the three genes of the family also share others regulatory activities. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP1742 CPTAC Assay Portal]
Authors
Glenda Nicioli Da Silva , Alex Pico , Kristina Hanspers , Andra Waagmeester , Denise Slenter , Eric Weitz , and Egon WillighagenActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- GediNET for discovering gene associations across diseases using knowledge based machine learning approach (2022).
- Integrative epigenetic profiling analysis identifies DNA methylation changes associated with chronic alcohol consumption (2015).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
CPTACAnnotations
Pathway Ontology
p53 signaling pathwayDisease Ontology
cancerLabel | Type | Compact URI | Comment |
---|---|---|---|
CDKN1A | GeneProduct | ensembl:ENSG00000124762 | |
BID | GeneProduct | ensembl:ENSG00000015475 | |
ABL1 | GeneProduct | ncbigene:25 | |
BOK | GeneProduct | ncbigene:666 | |
BAX | GeneProduct | ncbigene:581 | |
PMAIP1 | GeneProduct | ncbigene:5366 | |
MYC | GeneProduct | ncbigene:4609 | |
BCL2 | GeneProduct | ensembl:ENSG00000171791 | |
TP53 | GeneProduct | ncbigene:7157 | |
CDKN2A | GeneProduct | ncbigene:1029 | |
BBC3 | GeneProduct | ncbigene:27113 | |
TP73 | GeneProduct | ncbigene:7161 | |
GADD45A | GeneProduct | ncbigene:1647 | |
IGFBP-3 | GeneProduct | ensembl:ENSG00000235943 | |
TP63 | GeneProduct | ncbigene:8626 | |
ATM | GeneProduct | ensembl:ENSG00000149311 | |
OTX2 | GeneProduct | ensembl:ENSG00000165588 | |
MDM2 | GeneProduct | ensembl:ENSG00000135679 | |
TNFSF10 | GeneProduct | ncbigene:8743 | |
DeltaNp63gamma | Protein | uniprot:Q9H3D4 | |
TAp63beta | Protein | uniprot:Q9H3D4 | |
DelatNp63alpha | Protein | uniprot:Q9H3D4 | |
TP73 Delta Np73 | Protein | uniprot:O15350 | |
TP73zeta | Protein | uniprot:O15350 | |
SUMO1 | Protein | ncbigene:7341 | |
TP73delta | Protein | uniprot:O15350 | |
TP73alpha | Protein | uniprot:O15350 | |
TAp63gamma | Protein | uniprot:Q9H3D4 | |
TP73gamma | Protein | uniprot:O15350 | |
TP73beta | Protein | uniprot:O15350 | |
TAp63alpha | Protein | uniprot:Q9H3D4 | |
TP73epsilon | Protein | uniprot:O15350 | |
DeltaNp63beta | Protein | uniprot:Q9H3D4 |
References
- p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, et al. Mol Cell. 1998 Sep;2(3):305–16. PubMed Europe PMC Scholia
- p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, et al. Nature. 1999 Jun 24;399(6738):814–7. PubMed Europe PMC Scholia
- c-Abl: activation and nuclear targets. Shaul Y. Cell Death Differ. 2000 Jan;7(1):10–6. PubMed Europe PMC Scholia
- p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Dohn M, Zhang S, Chen X. Oncogene. 2001 May 31;20(25):3193–205. PubMed Europe PMC Scholia
- Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S. Cancer Res. 2002 Feb 1;62(3):636–41. PubMed Europe PMC Scholia
- Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Bunt J, de Haas TG, Hasselt NE, Zwijnenburg DA, Koster J, Versteeg R, et al. Mol Cancer Res. 2010 Oct;8(10):1344–57. PubMed Europe PMC Scholia